The DOI matches its Crossref record; 392 of the 392 references it cites were found in a registry or an index.
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–392 of 392
Cesari, R., Martin, E. S., Calin, G. A., Pentimalli, F., Bichi, R., McAdams, H., Trapasso, F., Drusco, A., Shimizu, M., Masciullo, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931262100 · Cited by 314
The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations
Geisler, S., Holmström, K. M., Treis, A., Skujat, D., Weber, S. S., Fiesel, F. C., Kahle, P. J., & Springer, W. (2010) · Autophagy · doi:10.4161/auto.6.7.13286 · Cited by 311 · cited 2×
“…adaptor protein p62 (also termed as SQSTM1, sequestosome-1), which links ubiquitinated cargo to the autophagic machinery by binding to both ubiquitin and LC3, has been described as an essential factor for parkin-induced mitophagy (Ding et al , 2010; Geisler et al , 2010a; Lee et al , 2010b).”
Wilson, M. A., Collins, J. L., Hod, Y., Ringe, D., & Petsko, G. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133288100 · Cited by 310
Greggio, E., Zambrano, I., Kaganovich, A., Beilina, A., Taymans, J.-M., Daniëls, V., Lewis, P., Jain, S., Ding, J., Syed, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708718200 · Cited by 308
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
Mortiboys, H., Johansen, K. K., Aasly, J. O., & Bandmann, O. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ff9685 · Cited by 307
Parisiadou, L., Xie, C., Cho, H. J., Lin, X., Gu, X.-L., Long, C.-X., Lobbestael, E., Baekelandt, V., Taymans, J.-M., Sun, L., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3799-09.2009 · Cited by 306
Redox imbalance in Parkinson's disease
Chinta, S. J., & Andersen, J. K. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.02.005 · Cited by 302
Sterky, F. H., Lee, S., Wibom, R., Olson, L., & Larsson, N.-G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103295108 · Cited by 299
Glutathione peroxidase activity in Parkinson's disease brain
Kish, S. J., Morito, C., & Hornykiewicz, O. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90078-3 · Cited by 299
Song, D. D., Shults, C. W., Sisk, A., Rockenstein, E., & Masliah, E. (2004) · Experimental Neurology · doi:10.1016/s0014-4886(03)00342-x · Cited by 295
Mitochondrial shape changes: orchestrating cell pathophysiology
Campello, S., & Scorrano, L. (2010) · EMBO reports · doi:10.1038/embor.2010.115 · Cited by 295
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
Lundblad, M., Decressac, M., Mattsson, B., & Björklund, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200575109 · Cited by 292
Weihofen, A., Thomas, K. J., Ostaszewski, B. L., Cookson, M. R., & Selkoe, D. J. (2009) · Biochemistry · doi:10.1021/bi8019178 · Cited by 290
Parkin Interacts with Ambra1 to Induce Mitophagy
Van Humbeeck, C., Cornelissen, T., Hofkens, H., Mandemakers, W., Gevaert, K., De Strooper, B., & Vandenberghe, W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1917-11.2011 · Cited by 287 · cited 1×
“Ambra1 (activating molecule in Beclin-regulated autophagy) was recently identified as a parkin-interacting protein that promotes autophagic clearance of mitochondria by activating class III PI3K, which is essential for the formation of phagophores (Van Humbeeck et al , 2011).”
Transplanted dopaminergic neurons develop PD pathologic changes: A second case report
Kordower, J. H., Chu, Y., Hauser, R. A., Olanow, C. W., & Freeman, T. B. (2008) · Movement Disorders · doi:10.1002/mds.22369 · Cited by 287
α-Synuclein and dopamine at the crossroads of Parkinson's disease
Venda, L. L., Cragg, S. J., Buchman, V. L., & Wade-Martins, R. (2010) · Trends in Neurosciences · doi:10.1016/j.tins.2010.09.004 · Cited by 285
Ko, H. S., Lee, Y., Shin, J.-H., Karuppagounder, S. S., Gadad, B. S., Koleske, A. J., Pletnikova, O., Troncoso, J. C., Dawson, V. L., & Dawson, T. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006083107 · Cited by 283
Jang, A., Lee, H., Suk, J., Jung, J., Kim, K., & Lee, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06695.x · Cited by 281
A Drosophila model for LRRK2 -linked parkinsonism
Liu, Z., Wang, X., Yu, Y., Li, X., Wang, T., Jiang, H., Ren, Q., Jiao, Y., Sawa, A., Moran, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708452105 · Cited by 279
Quintana, A., Kruse, S. E., Kapur, R. P., Sanz, E., & Palmiter, R. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006214107 · Cited by 279
Mitochondrial DNA mutations in disease and aging
Park, C. B., & Larsson, N.-G. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201010024 · Cited by 277
Blackinton, J., Lakshminarasimhan, M., Thomas, K. J., Ahmad, R., Greggio, E., Raza, A. S., Cookson, M. R., & Wilson, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806599200 · Cited by 275
Yadava, N., & Nicholls, D. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0212-07.2007 · Cited by 272
Antioxidant defense and aging in C. elegans: Is the oxidative damage theory of aging wrong?
Gems, D., & Doonan, R. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8595 · Cited by 264
Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP
Haque, M. E., Thomas, K. J., D'Souza, C., Callaghan, S., Kitada, T., Slack, R. S., Fraser, P., Cookson, M. R., Tandon, A., & Park, D. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705363105 · Cited by 263
Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila
Cha, G.-H., Kim, S., Park, J., Lee, E., Kim, M., Lee, S. B., Kim, J. M., Chung, J., & Cho, K. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500346102 · Cited by 263
Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy
Choubey, V., Safiulina, D., Vaarmann, A., Cagalinec, M., Wareski, P., Kuum, M., Zharkovsky, A., & Kaasik, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132514 · Cited by 262
Characterization of PINK1 processing, stability, and subcellular localization
Lin, W., & Kang, U. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05398.x · Cited by 262
Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration
Frank-Cannon, T. C., Tran, T., Ruhn, K. A., Martinez, T. N., Hong, J., Marvin, M., Hartley, M., Treviño, I., O'Brien, D. E., Casey, B., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3001-08.2008 · Cited by 261
Mitochondrial Lipid Abnormality and Electron Transport Chain Impairment in Mice Lacking α-Synuclein
Ellis, C. E., Murphy, E. J., Mitchell, D. C., Golovko, M. Y., Scaglia, F., Barceló-Coblijn, G. C., & Nussbaum, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10190-10201.2005 · Cited by 260
Mitsumoto, A., Nakagawa, Y., Takeuchi, A., Okawa, K., Iwamatsu, A., & Takanezawa, Y. (2001) · Free Radical Research · doi:10.1080/10715760100300831 · Cited by 257
Endocytic transport of integrins during cell migration and invasion
Caswell, P., & Norman, J. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.03.004 · Cited by 256
Caparros-Lefebvre, D., & Elbaz, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10166-6 · Cited by 255
Champy, P., Höglinger, G. U., Féger, J., Gleye, C., Hocquemiller, R., Laurens, A., Guérineau, V., Laprévote, O., Medja, F., Lombès, A., et al. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02138.x · Cited by 254
Fukui, H., & Moraes, C. T. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.008 · Cited by 250
PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy
Kawajiri, S., Saiki, S., Sato, S., Sato, F., Hatano, T., Eguchi, H., & Hattori, N. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.02.016 · Cited by 245
Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression
Wang, J., Silva, J. P., Gustafsson, C. M., Rustin, P., & Larsson, N.-G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061038798 · Cited by 245
Deng, J., Lewis, P. A., Greggio, E., Sluch, E., Beilina, A., & Cookson, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709098105 · Cited by 245
Localization of α-synuclein to mitochondria within midbrain of mice
Li, W.-W., Yang, R., Guo, J.-C., Ren, H.-M., Zha, X.-L., Cheng, J.-S., & Cai, D.-F. (2007) · NeuroReport · doi:10.1097/wnr.0b013e3282f03db4 · Cited by 244
Lee, S.-J., Kim, S. J., Kim, I.-K., Ko, J., Jeong, C.-S., Kim, G.-H., Park, C., Kang, S.-O., Suh, P.-G., Lee, H.-S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304517200 · Cited by 237
Choi, W.-S., Kruse, S. E., Palmiter, R. D., & Xia, Z. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807581105 · Cited by 236
Poulogiannis, G., McIntyre, R. E., Dimitriadi, M., Apps, J. R., Wilson, C. H., Ichimura, K., Luo, F., Cantley, L. C., Wyllie, A. H., Adams, D. J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009941107 · Cited by 236
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
Jellinger, K. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.07.006 · Cited by 232
Parkin promotes the ubiquitination and degradation of the mitochondrial fusion factor mitofusin 1
Glauser, L., Sonnay, S., Stafa, K., & Moore, D. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07318.x · Cited by 230
Meulener, M. C., Xu, K., Thomson, L., Ischiropoulos, H., & Bonini, N. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601891103 · Cited by 230
CSPα promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity
Sharma, M., Burré, J., & Südhof, T. C. (2011) · Nature Cell Biology · doi:10.1038/ncb2131 · Cited by 226
Van Laar, V. S., Arnold, B., Cassady, S. J., Chu, C. T., Burton, E. A., & Berman, S. B. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq531 · Cited by 225
Alterations in the common fragile site gene Parkin in ovarian and other cancers
Denison, S. R., Wang, F., Becker, N. A., Schüle, B., Kock, N., Phillips, L. A., Klein, C., & Smith, D. I. (2003) · Oncogene · doi:10.1038/sj.onc.1207072 · Cited by 224
Sriram, S. R., Li, X., Ko, H. S., Chung, K. K. K., Wong, E., Lim, K. L., Dawson, V. L., & Dawson, T. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi292 · Cited by 223
Constructing and decoding unconventional ubiquitin chains
Behrends, C., & Harper, J. W. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2066 · Cited by 223
Hamza, T. H., Chen, H., Hill-Burns, E. M., Rhodes, S. L., Montimurro, J., Kay, D. M., Tenesa, A., Kusel, V. I., Sheehan, P., Eaaswarkhanth, M., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002237 · Cited by 218
Parkin as a tumor suppressor gene for hepatocellular carcinoma
Fujiwara, M., Marusawa, H., Wang, H.-Q., Iwai, A., Ikeuchi, K., Imai, Y., Kataoka, A., Nukina, N., Takahashi, R., & Chiba, T. (2008) · Oncogene · doi:10.1038/onc.2008.199 · Cited by 218
Li, J., Englund, E., Widner, H., Rehncrona, S., Björklund, A., Lindvall, O., & Brundin, P. (2010) · Movement Disorders · doi:10.1002/mds.23012 · Cited by 216
Mysterious oligomerization of the amyloidogenic proteins
Uversky, V. N. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07721.x · Cited by 215
Imam, S. Z., Zhou, Q., Yamamoto, A., Valente, A. J., Ali, S. F., Bains, M., Roberts, J. L., Kahle, P. J., Clark, R. A., & Li, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.1833-10.2011 · Cited by 214
MicroRNAs and Metabolism Crosstalk in Energy Homeostasis
Dumortier, O., Hinault, C., & Van Obberghen, E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.004 · Cited by 214
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
Klivenyi, P., Siwek, D., Gardian, G., Yang, L., Starkov, A., Cleren, C., Ferrante, R. J., Kowall, N. W., Abeliovich, A., & Beal, M. F. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.018 · Cited by 213
Molecular mechanisms of α-synuclein neurodegeneration
Waxman, E. A., & Giasson, B. I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.013 · Cited by 213
da Costa, C. A., Sunyach, C., Giaime, E., West, A., Corti, O., Brice, A., Safe, S., Abou-Sleiman, P. M., Wood, N. W., Takahashi, H., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1981 · Cited by 212
Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells
Kim, K.-Y., Stevens, M. V., Akter, M. H., Rusk, S. E., Huang, R. J., Cohen, A., Noguchi, A., Springer, D., Bocharov, A. V., Eggerman, T. L., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44736 · Cited by 211
Parkin Protects against LRRK2 G2019S Mutant-Induced Dopaminergic Neurodegeneration in Drosophila
Ng, C.-H., Mok, S. Z. S., Koh, C., Ouyang, X., Fivaz, M. L., Tan, E.-K., Dawson, V. L., Dawson, T. M., Yu, F., & Lim, K.-L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2375-09.2009 · Cited by 211
Nakamura, K., Nemani, V. M., Wallender, E. K., Kaehlcke, K., Ott, M., & Edwards, R. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3088-08.2008 · Cited by 210
Cui, M., Tang, X., Christian, W. V., Yoon, Y., & Tieu, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.066662 · Cited by 207
Wang, C., Ko, H. S., Thomas, B., Tsang, F., Chew, K. C. M., Tay, S.-P., Ho, M. W. L., Lim, T.-M., Soong, T.-W., Pletnikova, O., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi413 · Cited by 207
Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6
Hoepken, H.-H., Gispert, S., Morales, B., Wingerter, O., Del Turco, D., Mülsch, A., Nussbaum, R. L., Müller, K., Dröse, S., Brandt, U., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.007 · Cited by 203
Liu, G., Zhang, C., Yin, J., Li, X., Cheng, F., Li, Y., Yang, H., Uéda, K., Chan, P., & Yu, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.02.056 · Cited by 201
Anwar, S., Peters, O., Millership, S., Ninkina, N., Doig, N., Connor-Robson, N., Threlfell, S., Kooner, G., Deacon, R. M., Bannerman, D. M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6194-10.2011 · Cited by 200
Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of α-Synuclein
Sung, J. Y., Kim, J., Paik, S. R., Park, J. H., Ahn, Y. S., & Chung, K. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101318200 · Cited by 200
Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance
Heeman, B., Van den Haute, C., Aelvoet, S.-A., Valsecchi, F., Rodenburg, R. J., Reumers, V., Debyser, Z., Callewaert, G., Koopman, W. J. H., Willems, P. H. G. M., et al. (2011) · Journal of Cell Science · doi:10.1242/jcs.078303 · Cited by 198
Gegg, M. E., Cooper, J. M., Schapira, A. H. V., & Taanman, J.-W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004756 · Cited by 198
The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax
Johnson, B. N., Berger, A. K., Cortese, G. P., & LaVoie, M. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113248109 · Cited by 189
Whitworth, A. J., Lee, J. R., Ho, V. M.-W., Flick, R., Chowdhury, R., & McQuibban, G. A. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000109 · Cited by 189
Selective Vulnerability of Dopaminergic Neurons to Microtubule Depolymerization
Ren, Y., Liu, W., Jiang, H., Jiang, Q., & Feng, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503483200 · Cited by 188
Gloeckner, C. J., Schumacher, A., Boldt, K., & Ueffing, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06024.x · Cited by 187
Mitochondrial translocation of α-synuclein is promoted by intracellular acidification
Cole, N. B., DiEuliis, D., Leo, P., Mitchell, D. C., & Nussbaum, R. L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.012 · Cited by 185
Sha, D., Chin, L.-S., & Li, L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp501 · Cited by 184
Choi, W.-S., Palmiter, R. D., & Xia, Z. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009132 · Cited by 183
Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization
Sen, S., Webber, P. J., & West, A. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025437 · Cited by 181
Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage
Stichel, C. C., Zhu, X.-R., Bader, V., Linnartz, B., Schmidt, S., & Lubbert, H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm083 · Cited by 179
Mandemakers, W., Morais, V. A., & De Strooper, B. (2007) · Journal of Cell Science · doi:10.1242/jcs.03443 · Cited by 176
Sandebring, A., Thomas, K. J., Beilina, A., van der Brug, M., Cleland, M. M., Ahmad, R., Miller, D. W., Zambrano, I., Cowburn, R. F., Behbahani, H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005701 · Cited by 176
Ho, C. C., Rideout, H. J., Ribé, E. M., Troy, C. M., & Dauer, W. T. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5175-08.2009 · Cited by 176
Su, L. J., Auluck, P. K., Outeiro, T. F., Yeger-Lotem, E., Kritzer, J. A., Tardiff, D. F., Strathearn, K. E., Liu, F., Cao, S., Hamamichi, S., et al. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.004267 · Cited by 174
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress
Muqit, M. M. K., Abou‐Sleiman, P. M., Saurin, A. T., Harvey, K., Gandhi, S., Deas, E., Eaton, S., Payne Smith, M. D., Venner, K., Matilla, A., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03845.x · Cited by 173
Cell systems and the toxic mechanism(s) of α-synuclein
Cookson, M. R., & van der Brug, M. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.022 · Cited by 173
Parkin Mediates Neuroprotection through Activation of IκB Kinase/Nuclear Factor-κB Signaling
Henn, I. H., Bouman, L., Schlehe, J. S., Schlierf, A., Schramm, J. E., Wegener, E., Nakaso, K., Culmsee, C., Berninger, B., Krappmann, D., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5537-06.2007 · Cited by 173
Self-citationCancer and Neurodegeneration: Between the Devil and the Deep Blue Sea
Plun-Favreau, H., Lewis, P. A., Hardy, J., Martins, L. M., & Wood, N. W. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001257 · Cited by 173
What Determines the Specificity and Outcomes of Ubiquitin Signaling?
Ikeda, F., Crosetto, N., & Dikic, I. (2010) · Cell · doi:10.1016/j.cell.2010.10.026 · Cited by 172
Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease
Shi, G., Lee, J. R., Grimes, D. A., Racacho, L., Ye, D., Yang, H., Ross, O. A., Farrer, M., McQuibban, G. A., & Bulman, D. E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr077 · Cited by 171
Lannuzel, A., Michel, P. P., Höglinger, G. U., Champy, P., Jousset, A., Medja, F., Lombès, A., Darios, F., Gleye, C., Laurens, A., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00441-x · Cited by 168
Positioning mitochondrial plasticity within cellular signaling cascades
Soubannier, V., & McBride, H. M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.008 · Cited by 164
RING finger 1 mutations in Parkin produce altered localization of the protein
Cookson, M. R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg328 · Cited by 162
Mitochondrial localization of alpha-synuclein protein in alpha-synuclein overexpressing cells
Shavali, S., Brown-Borg, H. M., Ebadi, M., & Porter, J. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.005 · Cited by 160
Casarejos, M. J., Menéndez, J., Solano, R. M., Rodríguez‐Navarro, J. A., de Yébenes, J. G., & Mena, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03777.x · Cited by 160
Mutant Parkin Impairs Mitochondrial Function and Morphology in Human Fibroblasts
Grünewald, A., Voges, L., Raković, A., Kasten, M., Vandebona, H., Hemmelmann, C., Lohmann, K., Orolicki, S., Ramírez, A., Schapira, A. H. V., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012962 · Cited by 160
Dusonchet, J., Kochubey, O., Stafa, K., Young, S., Zufferey, R., Moore, D. J., Schneider, B. L., & Aebischer, P. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5092-10.2011 · Cited by 160
The Parkinson’s disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites
Greggio, E., Taymans, J., Zhen, Y., Ryder, J. W., Vancraenenbroeck, R., Beilina, A. G., Sun, P., Deng, J., Jaffe, H., Baekelandt, V., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.163 · Cited by 159
A tale on animal models of Parkinson's disease
Bezard, E., & Przedborski, S. (2011) · Movement Disorders · doi:10.1002/mds.23696 · Cited by 159
A deadly spread: cellular mechanisms of α-synuclein transfer
Steiner, J. A., Angot, É., & Brundin, P. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.53 · Cited by 159
Gotthardt, K., Weyand, M., Kortholt, A., Van Haastert, P. J. M., & Wittinghofer, A. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.150 · Cited by 159
Parkinson's disease and cancer: two wars, one front
Devine, M. J., Plun‐Favreau, H., & Wood, N. W. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3150 · Cited by 158
Mitochondrial dynamics in Parkinson's disease
Laar, V. S. V., & Berman, S. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.019 · Cited by 156
Gloeckner, C. J., Boldt, K., von Zweydorf, F., Helm, S., Wiesent, L., Sarioglu, H., & Ueffing, M. (2010) · Journal of Proteome Research · doi:10.1021/pr9008578 · Cited by 155
PINK1 function in health and disease
Deas, E., Plun‐Favreau, H., & Wood, N. W. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900024 · Cited by 154
Novel Monoclonal Antibodies Demonstrate Biochemical Variation of Brain Parkin with Age
Pawlyk, A. C., Giasson, B. I., Sampathu, D. M., Perez, F. A., Lim, K. L., Dawson, V. L., Dawson, T. M., Palmiter, R. D., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306889200 · Cited by 151
Mitochondrial alterations in Parkinson’s disease: new clues
Vila, M., Ramonet, D., & Perier, C. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05604.x · Cited by 150
Liu, Z., Hamamichi, S., Lee, B. D., Yang, D., Ray, A., Caldwell, G. A., Caldwell, K. A., Dawson, T. M., Smith, W. W., & Dawson, V. L. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr312 · Cited by 150
Mitochondrial DNA Mutations in Disease, Aging, and Neurodegeneration
Reeve, A. K., Krishnan, K. J., & Turnbull, D. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.016 · Cited by 149
Webber, P. J., Smith, A. D., Sen, S., Renfrow, M. B., Mobley, J. A., & West, A. B. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.07.033 · Cited by 149
Dagda, R. K., Gusdon, A. M., Pien, I., Strack, S., Green, S., Li, C., Houten, B. V., Cherra, S. J., & Chu, C. T. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.74 · Cited by 147
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
Schlüter, O. M., Fornai, F., Alessandri, M., TAKAMORI, S., Geppert, M., Jahn, R., & Südhof, T. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00036-8 · Cited by 147
Denison, S. R., Callahan, G., Becker, N. A., Phillips, L. A., & Smith, D. I. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10236 · Cited by 146
A New Cytosolic Pathway from a Parkinson Disease-associated Kinase, BRPK/PINK1
Murata, H., Sakaguchi, M., Yu, J. Z., Sakaguchi, Y. M., Futami, J., Yamada, H., Kataoka, K., & Huh, N.-H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179390 · Cited by 145
Hristova, V. A., Beasley, S., Rylett, R. J., & Shaw, G. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808700200 · Cited by 145
The Mitochondrial Chaperone Protein TRAP1 Mitigates α-Synuclein Toxicity
Butler, E. K., Voigt, A., Lutz, A. K., Toegel, J. P., Gerhardt, E., Karsten, P., Falkenburger, B. H., Reinartz, A., Winklhofer, K. F., & Schulz, J. B. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002488 · Cited by 144
Self-citationIncidental Lewy body disease: Clinical comparison to a control cohort
Adler, C. H., Connor, D. J., Hentz, J. G., Sabbagh, M. N., Caviness, J. N., Shill, H. A., Noble, B., & Beach, T. G. (2010) · Movement Disorders · doi:10.1002/mds.22971 · Cited by 143
Inactivation of Parkin by Oxidative Stress and C-terminal Truncations
Winklhofer, K. F., Henn, I. H., Kay-Jackson, P. C., Heller, U., & Tatzelt, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306769200 · Cited by 143
Self-citationPark, J., Kim, K. S., Lee, S., Ryu, J., Chung, K. C., Choo, Y., Jou, I., Kim, J., & Park, S. M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06150.x · Cited by 135
Zhang, L., Zhang, C., Zhu, Y., Cai, Q., Chan, P., Uéda, K., Yu, S., & Yang, H. (2008) · Brain Research · doi:10.1016/j.brainres.2008.08.067 · Cited by 134
Wang, H., Chou, A.-H., Wu, A.-S., Chen, S.-Y., Weng, Y.-H., Kao, Y.-C., Yeh, T., Chu, P., & Lu, C.-S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.007 · Cited by 133
Mitochondrial complex III stabilizes complex I in the absence of NDUFS4 to provide partial activity
Calvaruso, M. A., Willems, P. H. G. M., van den Brand, M., Valsecchi, F., Kruse, S. E., Palmiter, R. D., Smeitink, J. A. M., & Nijtmans, L. G. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr446 · Cited by 132
Pilsl, A., & Winklhofer, K. F. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0902-3 · Cited by 131
Self-citationAlterations of the Tumor Suppressor Gene Parkin in Non-Small Cell Lung Cancer
Picchio, M. C., Martin, E. S., Cesari, R., Calin, G. A., Yendamuri, S., Kuroki, T., Pentimalli, F., Sarti, M., Yoder, K. E., Kaiser, L. R., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0086 · Cited by 131
Rathke‐Hartlieb, S., Kahle, P. J., Neumann, M., Ozmen, L., Haid, S., Okochi, M., Haass, C., & Schulz, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00366.x · Cited by 128
Self-citationPickrell, A. M., Pinto, M., Hida, A., & Moraes, C. T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4871-11.2011 · Cited by 128
Stafa, K., Trancikova, A., Webber, P. J., Glauser, L., West, A. B., & Moore, D. J. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002526 · Cited by 127
Paterna, J., Leng, A., Weber, E., Feldon, J., & Büeler, H. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300067 · Cited by 126
Richardson, J. R., Caudle, W. M., Guillot, T. S., Watson, J. L., Nakamaru‐Ogiso, E., Seo, B. B., Sherer, T., Greenamyre, J. T., Yagi, T., Matsuno‐Yagi, A., et al. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl133 · Cited by 124
Loeb, V., Yakunin, E., Saada, A., & Sharon, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.061051 · Cited by 124
Parkin: a multifaceted ubiquitin ligase
Moore, D. J. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340749 · Cited by 123
Identification of the Autophosphorylation Sites of LRRK2
Kamikawaji, S., Ito, G., & Iwatsubo, T. (2009) · Biochemistry · doi:10.1021/bi9011379 · Cited by 123
Binding of α-Synuclein Affects the Lipid Packing in Bilayers of Small Vesicles
Kamp, F., & Beyer, K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512292200 · Cited by 123
Wang, C., Tan, J. M. M., Ho, M. W. L., Zaiden, N., Wong, S. H., Chew, C. L. C., Eng, P. W., Lim, T. M., Dawson, T. M., & Lim, K. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03023.x · Cited by 122
Parkin gene alterations in hepatocellular carcinoma
Wang, F., Denison, S. R., Lai, J., Philips, L. A., Montoya, D., Kock, N., Schüle, B., Klein, C., Shridhar, V., Roberts, L. R., et al. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20020 · Cited by 119
The Yeast Complex I Equivalent NADH Dehydrogenase Rescues pink1 Mutants
Vilain, S., Esposito, G., Haddad, D., Schaap, O., Dobreva, M. P., Vos, M. H., Meensel, S. V., Morais, V. A., Strooper, B. D., & Verstreken, P. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002456 · Cited by 118
Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease
Marella, M., Seo, B. B., Nakamaru-Ogiso, E., Greenamyre, J. T., Matsuno-Yagi, A., & Yagi, T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001433 · Cited by 116
Tay, S.-P., Yeo, C. W. S., Chai, C., Chua, P., Tan, H.-M., Ang, A. X. Y., Yip, D. L. H., Sung, J.-X., Tan, P. H., Bay, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108241 · Cited by 114
ArfGAP1 Is a GTPase Activating Protein for LRRK2: Reciprocal Regulation of ArfGAP1 by LRRK2
Xiong, Y., Yuan, C., Chen, R., Dawson, T. M., & Dawson, V. L. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4566-11.2012 · Cited by 112
Neurodegenerative phenotypes in an A53T -synuclein transgenic mouse model are independent of LRRK2
Daher, J. P. L., Pletniková, O., Biskup, S., Musso, A., Gellhaar, S., Galter, D., Troncoso, J. C., Lee, M. K., Dawson, T. M., Dawson, V. L., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds057 · Cited by 111
Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation
Piccoli, C., Sardanelli, A. M., Scrima, R., Ripoli, M. C., Quarato, G., D’Aprile, A., Bellomo, F., Scacco, S., Michele, G. D., Filla, A., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9729-2 · Cited by 109
Mechanistic aspects of Parkinson’s disease: α-synuclein and the biomembrane
Beyer, K. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0014-9 · Cited by 105
Agirre, X., Román‐Gómez, J., Vázquez, I., Jiménez‐Velasco, A., Gárate, L., Montiel‐Duarte, C., Artieda-Urrutia, P., Cordeu, L., Lahortiga, I., Calasanz, M. J., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21584 · Cited by 104
Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 103
Kanao, T., Venderová, K., Park, D. S., Unterman, T. G., Lu, B., & Imai, Y. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq289 · Cited by 103
Parkin Pathway Activation Mitigates Glioma Cell Proliferation and Predicts Patient Survival
Yeo, C. W. S., Ng, F., Chai, C., Tan, J. M. M., Koh, G. R. H., Chong, Y. K., Koh, L., Foong, C. S. F., Sandanaraj, E., Holbrook, J. D., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3060 · Cited by 101
Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease
Büeler, H. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0465-0 · Cited by 94
Wong, E. S. P., Tan, J. M. M., Wang, C., Zhang, Z., Tay, S.-P., Zaiden, N., Ko, H. S., Dawson, V. L., Dawson, T. M., & Lim, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609466200 · Cited by 92
The effects of oxidative stress on parkin and other E3 ligases
LaVoie, M. J., Cortese, G. P., Ostaszewski, B. L., & Schlossmacher, M. G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04911.x · Cited by 90
Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model
Khandelwal, P. J., Dumanis, S. B., Feng, L., Maguire‐Zeiss, K. A., Rebeck, G. W., Lashuel, H. A., & Moussa, C. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-47 · Cited by 90
Parkin Protects against Mitochondrial Toxins and β-Amyloid Accumulation in Skeletal Muscle Cells
Rosen, K. M., Veereshwarayya, V., Moussa, C., Fu, Q., Goldberg, M. S., Schlossmacher, M. G., Shen, J., & Querfurth, H. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512649200 · Cited by 87
In Vivo Complementation of Complex I by the Yeast Ndi1 Enzyme
Seo, B. B., Nakamaru‐Ogiso, E., Flotte, T. R., Matsuno‐Yagi, A., & Yagi, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600922200 · Cited by 86
LRRK2 signaling pathways: the key to unlocking neurodegeneration?
Berwick, D. C., & Harvey, K. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.01.001 · Cited by 86
Gu, W., Corti, O., Araujo, F., Hampe, C., Jacquier, S., Lücking, C. B., Abbas, N., Duyckaerts, C. J., Rooney, T., Pradier, L., et al. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.011 · Cited by 85
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease
Hansen, C., & Li, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.03.002 · Cited by 85
DJ‐1, PINK1, and their effects on mitochondrial pathways
Cookson, M. (2010) · Movement Disorders · doi:10.1002/mds.22713 · Cited by 85
Sterky, F. H., Hoffman, A. F., Milenkovic, D., Bao, B., Paganelli, A., Edgar, D., Wibom, R., Lupica, C. R., Olson, L., & Larsson, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr537 · Cited by 85
Haque, M. E., Mount, M. P., Safarpour, F., Abdel-Messih, E., Callaghan, S., Mazerolle, C., Kitada, T., Slack, R. S., Wallace, V., Shen, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.346437 · Cited by 84 · cited 3×
“…by an increased vulnerability to mitochondrial damage (Casarejos et al , 2006; Rosen et al , 2006; Henn et al , 2007; Paterna et al , 2007; Haque et al , 2008, 2012; Sandebring et al , 2009), indicating that mitochondrial alterations can be compensated under basal but not under stress…”
Parkin selectively alters the intrinsic threshold for mitochondrial cytochrome c release
Berger, A. K., Cortese, G. P., Amodeo, K. D., Weihofen, A., Letai, A. G., & LaVoie, M. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp384 · Cited by 84
Amo, T., Sato, S., Saiki, S., Wolf, A. M., Toyomizu, M., Gautier, C., Shen, J., Ohta, S., & Hattori, N. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.027 · Cited by 83
Hasegawa, T., Treis, A., Patenge, N., Fiesel, F. C., Springer, W., & Kahle, P. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05277.x · Cited by 79
Some ribosome-inactivating proteins depurinate ribosomal RNA at multiple sites
Barbieri, L., Ferreras, J. M., Barraco, A., et al. (1992) · Biochemical Journal · doi:10.1042/bj2860001 · Cited by 77
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity
Perez, F. A., Curtis, W., & Palmiter, R. D. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-71 · Cited by 75
Neuronal specificity of α-synuclein toxicity and effect of Parkin co-expression in primates
Yasuda, T., Miyachi, S., Kitagawa, R., Wada, K., Nihira, T., Ren, Y., Hirai, Y., Ageyama, N., Terao, K., Shimada, T., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.09.052 · Cited by 75
Mechanisms of LRRK2-Mediated Neurodegeneration
Tsika, E., & Moore, D. J. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0265-8 · Cited by 74
Liu, M., Dobson, B., Glicksman, M. A., Yue, Z., & Stein, R. L. (2010) · Biochemistry · doi:10.1021/bi901851y · Cited by 72
Less than perfect divorces: dysregulated mitochondrial fission and neurodegeneration
Oettinghaus, B., Licci, M., Scorrano, L., & Frank, S. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0930-z · Cited by 71
A New Evolutionary Paradigm for the Parkinson Disease Gene DJ-1
Lucas‐Lledó, J. I., & Marı́n, I. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl186 · Cited by 71
Thomas, B., von Coelln, R., Mandir, A. S., Trinkaus, D. B., Farah, M. H., Lim, K. L., Calingasan, N. Y., Beal, M. F., Dawson, V. L., & Dawson, T. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.12.021 · Cited by 70
Parkin stabilizes PINK1 through direct interaction
Shiba, K., Arai, T., Sato, S., Kubo, S., Ohba, Y., Mizuno, Y., & Hattori, N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.006 · Cited by 70
Clues to how alpha‐synuclein damages neurons in Parkinson's disease
Sulzer, D. (2010) · Movement Disorders · doi:10.1002/mds.22639 · Cited by 69
Matenia, D., Hempp, C., Timm, T., Eikhof, A., & Mandelkow, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262287 · Cited by 68
Molecular interaction between parkin and PINK1 in mammalian neuronal cells
Um, J. W., Stichel-Gunkel, C. C., Lübbert, H., Lee, G., & Chung, K. C. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.12.010 · Cited by 63
Morphological characteristics of dendrite bundles in the lumbar spinal cord of the rat
Anderson, W. J., Stromberg, M. W., & Hinsman, E. J. (1976) · Brain Research · doi:10.1016/0006-8993(76)90398-x · Cited by 62
N-myc Regulates Parkin Expression
West, A. B., Kapatos, G., O’Farrell, C., de Chavez, F. G., Chiu, K., Farrer, M. J., & Maidment, N. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400126200 · Cited by 61
Biegel, J. A., RORKE, L. B., Janss, A. J., Sutton, L. N., & Parmiter, A. H. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870140202 · Cited by 58
POLG1-Related and other “Mitochondrial Parkinsonisms”: an Overview
Orsucci, D., Ienco, E. C., Mancuso, M., & Siciliano, G. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9488-9 · Cited by 56
Aberrant Folding of Pathogenic Parkin Mutants
Schlehe, J. S., Lutz, A. K., Pilsl, A., Lämmermann, K., Grgur, K., Henn, I. H., Tatzelt, J., & Winklhofer, K. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707494200 · Cited by 55
Self-citationα-Synuclein expression in HEK293 cells enhances the mitochondrial sensitivity to rotenone
Orth, M., Tabrizi, S. J., Schapira, A. H. V., & Cooper, J. A. D. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00941-8 · Cited by 53
Zach, S., Felk, S., & Gillardon, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013191 · Cited by 52
Dong, Z., Ferger, B., Feldon, J., & Büeler, H. (2002) · Journal of Neurobiology · doi:10.1002/neu.10094 · Cited by 49
Parkin Deficiency Delays Motor Decline and Disease Manifestation in a Mouse Model of Synucleinopathy
Fournier, M., Vitte, J., Garrigue, J., Langui, D., Dullin, J.-P., Saurini, F., Hanoun, N., Pérez-Díaz, F., Cornilleau, F., Joubert, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006629 · Cited by 46
Self-citationBalance is the challenge – The impact of mitochondrial dynamics in Parkinson’s disease
Burbulla, L. F., Krebiehl, G., & Krüger, R. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02354.x · Cited by 46
Ikeuchi, K., Marusawa, H., Fujiwara, M., Matsumoto, Y. M., Endo, Y., Watanabe, T., Iwai, A., Sakai, Y., Takahashi, R., & Chiba, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24565 · Cited by 45
Computational studies of Family A and Family B GPCRs
Vohra, S., Chintapalli, S. V., Illingworth, C. J. R., Reeves, P. J., Mullineaux, P. M., Clark, H. S. X., Dean, M. K., UPTON, G. J. G., & Reynolds, C. A. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350749 · Cited by 45
On the Road to Leucine-Rich Repeat Kinase 2 Signalling: Evidence from Cellular and in vivo Studies
Daniëls, V., Baekelandt, V., & Taymans, J. (2011) · Neurosignals · doi:10.1159/000324488 · Cited by 44
Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress
Klinkenberg, M., Thurow, N., Gispert, S., Ricciardi, F., Eich, F., Prehn, J. H. M., Auburger, G. W. J., & Kögel, D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.068 · Cited by 41
Animal models in neurodegenerative diseases
Hirsch, É. C. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_11 · Cited by 39
The synapsin I brain distribution in ischemia
Kitagawa, K., Matsumoto, M., Sobue, K., Tagaya, M., Okabe, T., Niinobe, M., Ohtsuki, T., Handa, N., Kimura, K., Mikoshiba, K., et al. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90051-3 · Cited by 39
Paterna, J., Leng, A., Weber, E., Feldon, J., & Büeler, H. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300154 · Cited by 38
Carreira, B. P., Morte, M. I., Lourenço, A. S., Santos, A. I., Inácio, Â. S., Ambrósio, A. F., Carvalho, C. M., & Araújo, I. M. (2012) · Neurosignals · doi:10.1159/000332811 · Cited by 26
Yuan, X.-L., Guo, J., Shi, Z., Zhi-qian, X., Yan, X., Zhao, B., & Tang, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.005 · Cited by 17
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Ubiquitin is phosphorylated by PINK1 to activate parkin
Koyano, F., Okatsu, K., Kosako, H., Tamura, Y., Go, E., Kimura, M., Kimura, Y., Tsuchiya, H., Yoshihara, H., Hirokawa, T., et al. (2014) · Nature · doi:10.1038/nature13392 · Cited by 1,477
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Xicoy, H., Wieringa, B., & Martens, G. J. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0149-0 · Cited by 1,036
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Neuronal calcium signaling: function and dysfunction
Brini, M., Calì, T., Ottolini, D., & Carafoli, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1550-7 · Cited by 748
Metadata
- Authors
- Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F.
- Venue
- The EMBO Journal
- Published
- 2012-06-26
- Volume
- 31
- Issue
- 14
- Pages
- 3038-3062
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2109326232
- Cited by
- 642
- References
- 392
- FWCI
- 37.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.